logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Ardea Biosciences, Inc


USPTO Granted Patents = 63

% Expired Patents = 60.3



Forward Citations = 495

Loading Chart...
Loading Chart...

43 inventors (with patents filed for the assignee):

goldMedal Jean-Luc Girardet (30 out of 35 patents)

silverMedal Zhi Hong (21 out of 39 patents)

bronzeMedal Jean-Michel Andre Vernier (20 out of 56 patents)

4.  Esmir Gunic (19 out of 23 patents)

5.  Yung-Hyo Koh (14 out of 17 patents)

6.  Barry D Quart (12 out of 19 patents)

7.  Andreas Maderna (9 out of 23 patents)

8.  Stanley Lang (9 out of 10 patents)

9.  Martha Alicia De La Rosa (8 out of 24 patents)

10.  Samedy Ouk (7 out of 23 patents)

11.  Li-Tain Yeh (7 out of 7 patents)

12.  Stuart Dimock (6 out of 7 patents)

13.  David A Paisner (5 out of 12 patents)

14.  Jeffrey Miner (5 out of 5 patents)

15.  Dinesh Barawkar (5 out of 5 patents)


Core Competencies:
CXCR-2 Inhibitors
Thioacetate Compounds
MEK Inhibitors
HIV Reverse Transcriptase
Pyridine Compounds
Polymorphic Forms
Uric Acid Modulation
Cancer Treatments
Pharmaceutical Compositions
Sulfonamides
Dihydropyridin Compounds
Purines

63 patents:

1. 10919858 - Thioacetate compounds, compositions and methods of use (2021-02-16),
2. 10772886 - CXCR-2 inhibitors for treating crystal arthropathy disorders (2020-09-15),
3. 10570095 - 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same (2020-02-25),
4. 10266493 - Thioacetate compounds, compositions and methods of use (2019-04-23),
5. 10183012 - Compounds and compositions and methods of use (2019-01-22),
6. 10047050 - 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same (2018-08-14),
7. 9956205 - Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof (2018-05-01),
8. 9402827 - Treatment of gout (2016-08-02),
9. 9296709 - Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid (2016-03-29),
10. 9296686 - Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide (2016-03-29),
11. 9220696 - Pharmaceutical combinations for treatment of specific cancers (2015-12-29),
12. 9216179 - Treatment of gout and hyperuricemia (2015-12-22),
13. 9212135 - Phenylthioacetate compounds, compositions and methods of use (2015-12-15),
14. 9174933 - Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof (2015-11-03),
15. 9095581 - Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof (2015-08-04),
Ardea Biosciences, Inc. is a biotechnology company that specializes in the discovery and development of small-molecule therapeutics. They focus on developing innovative treatments for various diseases including cancer, viral infections, and inflammatory disorders. Ardea Biosciences uses a proprietary chemistry platform to design and optimize their drug candidates, aiming to provide effective and targeted therapies for patients in need.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Ardea Biosciences, Inc
63 Patents

#99 in San Diego, CA

#1,343 in California

#5,753 in US

#11,611 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Ardea Biosciences, Inc

Forward Citations = 495

43 inventors:

goldMedal Jean-Luc Girardet (30 out of 35 patents)

silverMedal Zhi Hong (21 out of 39 patents)

bronzeMedal Jean-Michel Andre Vernier (20 out of 56 patents)

4.  Esmir Gunic (19 out of 23 patents)

5.  Yung-Hyo Koh (14 out of 17 patents)

Please report any incorrect information to [email protected]
Loading…